Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

TNFα antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation.

Carcinogenesis | 2022

Benzo[a]pyrene (B[a]P) is a typical complete carcinogen in tobacco, but its mechanism of inducing the development of chronic pneumonia and consequent lung cancer is unclear. Here we elucidated the role of myeloid-derived suppressor cells (MDSCs) in developing B[a]P-induced chronic lung inflammation and efficacy of immunotherapy in preventing subsequent malignant transformation. Our study showed that as B[a]P could induce the accumulation of MDSCs in lung tissues and enhance the immunosuppressive effect regulated by cytokines and metabolites, thereby promoting the formation of immunosuppressive microenvironment, where effector T cells were exhausted, NK cells were dysfunctional, regulatory T (Treg) cells were expanded, polarized alveolar macrophages were transformed from M1 to M2. Subsequently, we performed the immunotherapy to block TNFɑ only or both TNFɑ and PD-1 at the early- or middle-stage of B[a]P-induced chronic lung inflammation to ameliorate the immunosuppressive microenvironment. We found that TNFɑ antagonist alone or with PD-1 blocker was shown to exert therapeutic effects on malignant transformation at the early stage of B[a]P-induced chronic lung inflammation. Taken together, our findings demonstrated that B[a]P-induced chronic lung inflammation resulted in the accumulation of MDSCs in lung tissues and exercise their immunosuppressive functions, thereby developing an immunosuppressive microenvironment, thus TNFɑ antagonist alone or with PD-1 blocker could prevent or retard the malignant transformation of B[a]P-induced chronic lung inflammation.

Pubmed ID: 35230387 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vimentin (D21H3) XP Rabbit mAb (antibody)

RRID:AB_10695459

This monoclonal targets Vimentin

View all literature mentions

N-Cadherin (D4R1H) XP Rabbit Antibody (antibody)

RRID:AB_2687616

This monoclonal targets N-Cadherin

View all literature mentions

E-Cadherin (24E10) Rabbit mAb (antibody)

RRID:AB_2291471

This monoclonal targets E-Cadherin (24E10) Rabbit mAb

View all literature mentions

FOXP3 antibody [2A11G9] (antibody)

RRID:AB_2104909

This monoclonal targets FOXP3 antibody [2A11G9]

View all literature mentions

APC anti-mouse CD49b (antibody)

RRID:AB_2566100

This monoclonal targets CD49b

View all literature mentions

APC anti-human CD8 (antibody)

RRID:AB_2616624

This monoclonal targets CD8

View all literature mentions

FITC anti-mouse CD3 (antibody)

RRID:AB_312660

This monoclonal targets CD3

View all literature mentions

APC anti-mouse/human CD11b (antibody)

RRID:AB_312794

This monoclonal targets CD11b

View all literature mentions

Image Pro Plus (software resource)

RRID:SCR_007369

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 18,2023. Software package to capture, process, measure, analyze and share images and data.

View all literature mentions

FlowJo (software resource)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions